Arnold Lippa

10.3k citations

91 papers · 8.5k indexed · 1 hit paper · h-index 34

Impact in

Cellular and Molecular Neuroscience top 0.2%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Pharmacology top 0.1%
- Cholinesterase and Neurodegenerative Diseases

Papers in

Cellular and Molecular Neuroscience 64
- Neuroscience and Neuropharmacology Research 57
- Neurotransmitter Receptor Influence on Behavior 18
Behavioral Neuroscience 5

Co-authors: Bernard Beer Raymond T. Bartus Reginald L. Dean Claire A. Klepner Mary Sano B. Beer Joseph Coupet D.J. Critchett
Journals: Pharmacology Biochemistry and Behavior (17 papers)European Journal of Pharmacology (6 papers)Life Sciences (6 papers)Biochemical Pharmacology (5 papers)Neurobiology of Aging (5 papers)
Partner nations: United States Slovenia Poland

In The Last Decade

Arnold Lippa

90 papers receiving 8.0k citations

Hit Papers

align trajectories log scale

The Cholinergic Hypothesis of Geriatric Memory Dysfunction 1982 · 4.5k citations

Peers

Countries citing papers authored by Arnold Lippa

Since Specialization

Citations

This map shows the geographic impact of Arnold Lippa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Lippa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Lippa more than expected).

Fields of papers citing papers by Arnold Lippa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold Lippa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Lippa. The network helps show where Arnold Lippa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Arnold Lippa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arnold Lippa Line = papers co-authored together Arnold Lippa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophrenia Journal of Psychiatric Research ·Daniel P. Radin, Rok Cerne, Jodi L. Smith, Jeffrey M. Witkin, Arnold Lippa	2025	1
2	AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit Biochemical Pharmacology ·Jeffrey M. Witkin, Daniel P. Radin, Sabhya Rana, David D. Fuller, Lili Suriani, 依田耕平, Nevil Maskelyne, Jodi L. Smith, Arnold Lippa, Rok Cerne	2024	7
3	Low-Impact Ampakine CX1739 Exerts Pro-Cognitive Effects and Reverses Opiate-Induced Respiratory Depression in Rodents SHILAP Revista de lepidopterología ·Daniel P. Radin, Sheng Zhong, Rok Cerne, Mohammed Shoaib, Jeffrey M. Witkin, Arnold Lippa	2024	12
4	High-Impact AMPAkines Elevate Calcium Levels in Cortical Astrocytes by Mobilizing Endoplasmic Reticular Calcium Stores SHILAP Revista de lepidopterología ·Daniel P. Radin, Rok Cerne, Jeffrey M. Witkin, Arnold Lippa	2024	1
5	Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy Pharmacology & Therapeutics ·Sabhya Rana, Lili Suriani, Jeffrey M. Witkin, Daniel P. Radin, Rok Cerne, Arnold Lippa, David D. Fuller	2024	3
6	High Impact AMPAkines Induce a Gq‐Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkines Synapse ·Daniel P. Radin, Sheng Zhong, Rok Cerne, Jeffrey M. Witkin, Arnold Lippa	2024	1
7	Nonsedating anxiolytics Pharmacology Biochemistry and Behavior ·Rok Cerne, Jodi L. Smith, Shisheng Cui, Arnold Lippa	2024	1
8	Comparative anticonvulsant activity of the GABAkine KRM‐II‐81 and a deuterated analog Drug Development Research ·Xingjie Ping, M.A. Gharaybeh, N. Tamilselvan, Lalit K. Golani, Mauro Teixeira, cho Hyunchoul, L M Patricot, Seyed Mahdi Sarkhosh Hosseini, Xiaoming Jin, Leggy A. Arnold, Rok Cerne, James M. Cook, Jiyou An, Miroslav M. Savić, Arnold Lippa, Jodi L. Smith, Jeffrey M. Witkin	2023	2
9	Potentiation of AMPA receptors for rapid therapeutic gain in psychiatry has reached a new level of excitement Neuropsychopharmacology ·Jeffrey M. Witkin, Arnold Lippa	2023	5
10	Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3‐selective GABAkine KRM‐II‐81 Biopharmaceutics & Drug Disposition ·Lalit K. Golani, Jiyou An, Mauro Teixeira, cho Hyunchoul, Qiaolifan Aerqin, Rok Cerne, N. Tamilselvan, M.A. Gharaybeh, Mahmud Rois, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, Jeffrey M. Schkeryantz, Leggy A. Arnold, James M. Cook, Miroslav M. Savić, Jeffrey M. Witkin	2022	5
11	Ampakines Attenuate Staurosporine-induced Cell Death in Primary Cortical Neurons: Implications in the ‘Chemo-Brain’ Phenomenon Anticancer Research ·Daniel P. Radin, Gary A. Rogers, Kimberley E. Hewitt, Yongtao Kang, Arnold Lippa	2018	8
12	Oncolytic Properties of Ampakines In Vitro Anticancer Research ·Daniel P. Radin, Yongtao Kang, Arnold Lippa	2018	10
13	Stargazin differentially modulates ampakine gating kinetics and pharmacology Biochemical Pharmacology ·Daniel P. Radin, Yongxin Li, Gary A. Rogers, Yongtao Kang, Arnold Lippa	2018	4
14	Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brain Biomedicine & Pharmacotherapy ·Daniel P. Radin, Steve A. Johnson, Yongtao Kang, Arnold Lippa	2018	22
15	A Multicenter, Placebo‐Controlled, Double‐Blind, Randomized Study of Efficacy and Safety of Ocinaplon (DOV 273,547) in Generalized Anxiety Disorder CNS Neuroscience & Therapeutics ·Pál Czobor, Phil Skolnick, Bernard Beer, Arnold Lippa	2009	23
16	Preclinical and Clinical Pharmacology of DOV 216,303, a “Triple” Reuptake Inhibitor CNS Drug Reviews ·Phil Skolnick, Philip A. Krieter, Joseph P. Tizzano, Anthony S. Basile, Piotr Popik, Pál Czobor, Arnold Lippa	2006	88
17	Pharmacological Profile of the “Triple” Monoamine Neurotransmitter Uptake Inhibitor, DOV 102,677 Cellular and Molecular Neurobiology ·Piotr Popik, Martyna Krawczyk, Krystyna Gołembiowska, Gabriel Nowak, Aaron Janowsky, Phil Skolnick, Arnold Lippa, Anthony S. Basile	2006	30
18	Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor European Journal of Pharmacology ·Phil Skolnick, Piotr Popik, Aaron Janowsky, Bernard Beer, Arnold Lippa	2003	117
19	Introduction. Overview of Citalopram Journal of Clinical Psychopharmacology ·Arnold Lippa, Bernard Beer, Robert Cancro	1999	1
20	Molecular substrates of anxiety: Clues from the heterogeneity of benzodiazepine receptors Life Sciences ·Arnold Lippa, Laurence R. Meyerson, Bernard Beer	1982	93

About Arnold Lippa

Arnold Lippa is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience, Biological Psychiatry, Psychiatry and Mental health and Neurology, having authored 91 papers that have together received 8.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (57 papers), Receptor Mechanisms and Signaling (21 papers), Neurotransmitter Receptor Influence on Behavior (18 papers), Memory and Neural Mechanisms (12 papers), Pharmacological Receptor Mechanisms and Effects (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Treatment of Major Depression (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (4.6k citations), Pharmacology (2.7k citations), Behavioral Neuroscience (479 citations), Cognitive Neuroscience (2.4k citations) and Biological Psychiatry (288 citations). Arnold Lippa has collaborated with scholars based in United States, Slovenia and Poland. Frequent co-authors include Bernard Beer, Raymond T. Bartus, Reginald L. Dean, Claire A. Klepner, Mary Sano, B. Beer, Joseph Coupet, D.J. Critchett, Phil Skolnick and Laurence R. Meyerson. Their work appears in journals such as Pharmacology Biochemistry and Behavior, European Journal of Pharmacology, Life Sciences, Biochemical Pharmacology and Neurobiology of Aging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact